Dossier
US compounding pharmacies
Coverage of US compounding pharmacies in the Nexus archive.
- FDA to discuss easing restrictions on peptides despite safety concerns
The FDA will hold a meeting in July to discuss easing restrictions on research peptides, which are currently sold in a gray market with limited safety and efficacy evidence. If restrictions are relaxed, US compounding pharmacies could legally produce and fill prescriptions for these peptides.